CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,726,894 | -29.2% | 575,440 | -18.6% | 0.01% | -21.4% |
| Q2 2023 | $9,504,822 | -23.0% | 707,204 | -5.0% | 0.01% | -26.3% |
| Q1 2023 | $12,345,618 | -18.7% | 744,609 | -8.8% | 0.02% | -26.9% |
| Q4 2022 | $15,194,154 | -20.7% | 816,890 | -45.3% | 0.03% | -18.8% |
| Q3 2022 | $19,149,000 | +112.9% | 1,492,625 | +16.3% | 0.03% | +128.6% |
| Q2 2022 | $8,994,000 | -24.0% | 1,283,045 | -10.1% | 0.01% | -12.5% |
| Q1 2022 | $11,833,000 | +39.5% | 1,427,445 | +13.9% | 0.02% | +45.5% |
| Q4 2021 | $8,484,000 | -3.3% | 1,253,200 | -24.3% | 0.01% | -8.3% |
| Q3 2021 | $8,776,000 | -20.9% | 1,655,752 | -14.2% | 0.01% | -20.0% |
| Q2 2021 | $11,095,000 | -12.5% | 1,929,486 | -29.8% | 0.02% | -21.1% |
| Q1 2021 | $12,674,000 | +42.1% | 2,749,179 | +2.9% | 0.02% | +26.7% |
| Q4 2020 | $8,921,000 | +22.7% | 2,671,337 | +9.1% | 0.02% | +7.1% |
| Q3 2020 | $7,270,000 | +10.7% | 2,447,837 | +72.2% | 0.01% | +7.7% |
| Q2 2020 | $6,568,000 | +65.7% | 1,421,749 | +38.1% | 0.01% | +44.4% |
| Q1 2020 | $3,963,000 | -40.3% | 1,029,468 | -41.9% | 0.01% | -10.0% |
| Q4 2019 | $6,642,000 | +18.6% | 1,771,283 | +68.0% | 0.01% | +11.1% |
| Q3 2019 | $5,599,000 | +236.9% | 1,054,476 | +143.6% | 0.01% | +200.0% |
| Q2 2019 | $1,662,000 | +230.4% | 432,929 | +338.4% | 0.00% | +200.0% |
| Q1 2019 | $503,000 | +87.7% | 98,744 | -29.4% | 0.00% | – |
| Q4 2018 | $268,000 | -67.8% | 139,878 | -36.5% | 0.00% | -100.0% |
| Q3 2018 | $833,000 | -13.2% | 220,403 | -28.4% | 0.00% | 0.0% |
| Q2 2018 | $960,000 | +131.3% | 307,870 | +77.3% | 0.00% | 0.0% |
| Q1 2018 | $415,000 | -11.5% | 173,670 | +44.5% | 0.00% | 0.0% |
| Q4 2017 | $469,000 | – | 120,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,378,584 | $3,116,000 | 2.30% |
| TANAKA CAPITAL MANAGEMENT INC | 147,993 | $298,000 | 0.90% |
| SOPHROSYNE CAPITAL LLC | 282,500 | $638,000 | 0.56% |
| Ghost Tree Capital, LLC | 200,000 | $452,000 | 0.27% |
| Orbimed Advisors | 1,895,000 | $4,283,000 | 0.05% |
| Financial Architects, Inc | 30,000 | $68,000 | 0.04% |
| Cowen Prime Services LLC | 43,550 | $98,000 | 0.04% |
| Rotella Capital Management, Inc. | 12,300 | $28,000 | 0.03% |
| FEDERATED HERMES, INC. | 3,267,000 | $7,384,000 | 0.02% |
| Baker Brothers Advisors | 569,853 | $1,288,000 | 0.02% |